Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

key opinion leaders

This page shows the latest key opinion leaders news and features for those working in and with pharma, biotech and healthcare.

A unique ecosystem

A unique ecosystem

For Medicen, it is also very important to focus on its key strategic areas and provide access and platforms for showcasing the latest research results in the field of life science. ... Start-ups from either cluster could attend B2B meetings and

Latest news

  • Harnessing the unrivalled power of key opinion leaders Harnessing the unrivalled power of key opinion leaders

    Harnessing the unrivalled power of key opinion leaders. The critical value of engaging KOLs early in the drug development process. ... Engaging early. Engaging the right key opinion leaders (KOLs) at an early stage in the life cycle, and utilising their

  • Spink wins gastroenterology society account Spink wins gastroenterology society account

    ESPGHAN’s annual congress is attended by over 4, 000 delegates and globally attracts key opinion leaders in the field of paediatric gastroenterology, hepatology and nutrition. ... Managing relations with the medical trade and global press, Spink will

  • Riding the wave of digital disruption Riding the wave of digital disruption

    And the key to thriving in this brave new world lies with the changing needs of the healthcare professional. ... Specifically, Gorini's team in Italy is working to use this customer data to tailor interactions with key opinion leaders to follow their

  • Connected Healthcare Connected Healthcare

    Despite the inexorable shift to digital, Cello's research has found that information received face-to-face from peers, key opinion leaders (KOLs), pharma sales representatives and sponsored conferences remain the

  • The changing role of the modern MSL The changing role of the modern MSL

    Smart Thinking blog. Insights and expert advice on the key issues facing today’ s pharma marketer. ... Put simply, “ KOLs [key opinion leaders] are demanding it,” stated Dyer.

More from news
Approximately 0 fully matching, plus 96 partially matching documents found.

Latest Intelligence

  • Developing advocacy in the pharmaceutical industry Developing advocacy in the pharmaceutical industry

    In fact, having open and honest relationships with your key opinion leaders (KOLs) is crucial to launching and growing a successful brand and is an important element of any business plan. ... The development of a charter is an elegant way of doing this

  • The Patient Journey

    the audience, whether this be patients, healthcare professionals or key opinion leaders. ... 5 Engage with key influencers throughout the patients’journeys. This allows the development of a robust strategic patient pathway.

  • How Augmented reality is disrupting healthcare How Augmented reality is disrupting healthcare

    Combining situational and sensorial learning via AR is an exciting way to improve information retention, deepen understanding of benefits and even pre-market complicated products to key opinion leaders. ... Forward-thinking companies will lead the  way

  • Understanding HCPs to build a meaningful brand Understanding HCPs to build a meaningful brand

    2. Add value to HCP Digital Opinion Leaders. Pharmaceutical companies that develop relationships with highly engaged online HCPs are likely to achieve better reach and engagement overall online. ... Conversely, your existing Key Opinion Leaders (KOLs)

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    Companies can help raise disease awareness by engaging with key opinion leaders (KOLs) and driving impactful campaigns using a multichannel communication approach. ... Companies can support these by ensuring that content is memorable, engaging and leaves

More from intelligence
Approximately 3 fully matching, plus 31 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • How can pharma engage with key stakeholders on NHS service transformation?

    Industry should also refine its proposition for transformation leads, medicines management staff and other key opinion leaders (KOLs), who may have different drivers and priorities. ... Pharma can also take a lead in facilitating discussions between

  • Developing advocacy in the pharmaceutical industry.

    In fact, having open and honest relationships with your key opinion leaders (KOLs) is crucial to launching and growing a successful brand and is an important element of any business plan. ... The development of a charter is an elegant way of doing this

  • Scrip World Pharmaceutical News

    We filter the flood of information on the industry and apply the knowledge of our extensive network of analysts, journalists and key opinion leaders to provide our readers with timely

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Quick links

Infographics

Multimedia